Abstract
Polyneuropathy (often also referred to as peripheral neuropathy) is a broad term that encompasses conditions characterized by a generalized disorder of peripheral nerves. Most commonly, patients present with sensory symptoms such as numbness or paresthesia starting in the toes/feet (i.e. following a length-dependent pattern). Common causes of polyneuropathy are diabetes mellitus, chronic alcoholism, nutritional deficiencies such as vitamin B12 and immune-mediated conditions (with leprosy or Hansen’s disease still considered among the leading causes of polyneuropathy worldwide, albeit rare in most developed countries). Each of these have distinct clinical and electrophysiological features. Hence a systematic and practical approach is needed for cost-effective diagnosis and early recognition of treatable forms of polyneuropathy.
The goal of electrodiagnostic studies is to confirm the presence of a polyneuropathy, assess the type of nerve fibers involved (sensory and/or motor), pattern, chronicity (and possibly tempo), pathophysiology (primarily axonal vs demyelinating) and its severity.
Nerve conduction studies (NCS) and needle electrode examination (NEE) aid in the classification and differentiation of peripheral neuropathies. The distinction between axonal and demyelinating neuropathies has diagnostic and prognostic implications. The routine electrodiagnostic evaluation of patients with suspected polyneuropathy includes sensory NCS, motor NCS, F-wave studies, H-wave studies and NEE. A wide variably exists amongst neurophysiologists regarding the use of electrodiagnostic examination techniques, reference values, interpretation of individual tests, and criteria for diagnosis and classification of peripheral neuropathy. However, the basic approaches are similar in most laboratories.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hanewinckel R, Drenthen J, van Oijen M, Hofman A, van Doorn PA, Ikram MA. Prevalence of polyneuropathy in the general middle-aged and elderly population. Neurology. 2016;87(18):1892–8.
Prior R, Van Helleputte L, Benoy V, Van Den Bosch L. Defective axonal transport: a common pathological mechanism in inherited and acquired peripheral neuropathies. Neurobiol Dis. 2017;105:300–20.
Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore). 1969;48(3):173–215.
Uncini A, Kuwabara S. Nodopathies of the peripheral nerve: an emerging concept. J Neurol Neurosurg Psychiatry. 2015;86(11):1186–95.
Barohn RJ, Amato AA. Pattern-recognition approach to neuropathy and neuronopathy. Neurol Clin. 2013;31(2):343–61.
Apfel SC, Asbury AK, Bril V, Burns TM, Campbell JN, Chalk CH, et al. Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci. 2001;189(1–2):3–5.
Terkelsen AJ, Karlsson P, Lauria G, Freeman R, Finnerup NB, Jensen TS. The diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, and causes. Lancet Neurol. 2017;16(11):934–44.
Pasnoor M, Dimachkie MM, Kluding P, Barohn RJ. Diabetic neuropathy. Part 1: Overview and symmetric phenotypes. Neurol Clin. 2013;31(2):425–45.
Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521–34.
Klein CJ, Duan X, Shy ME. Inherited neuropathies: clinical overview and update. Muscle Nerve. 2013;48(4):604–22.
Katz JS, Saperstein DS, Gronseth G, Amato AA, Barohn RJ. Distal acquired demyelinating symmetric neuropathy. Neurology. 2000;54(3):615–20.
Kissel JT, Mendell JR. Neuropathies associated with monoclonal gammopathies. Neuromuscul Disord. 1996;6(1):3–18.
Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barre syndrome. Lancet. 2016;388(10045):717–27.
Peltier AC, Donofrio PD. Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside. Semin Neurol. 2012;32(3):187–95.
Rison RA, Beydoun SR. Paraproteinemic neuropathy: a practical review. BMC Neurol. 2016;16:13.
Cho SC, Siao-Tick-Chong P, So YT. Clinical utility of electrodiagnostic consultation in suspected polyneuropathy. Muscle Nerve. 2004;30(5):659–62.
Gilliatt RW, Sears TA. Sensory nerve action potentials in patients with peripheral nerve lesions. J Neurol Neurosurg Psychiatry. 1958;21(2):109–18.
Barnett C, Perkins BA, Ngo M, Todorov S, Leung R, Bril V. Sural-to-radial amplitude ratio in the diagnosis of diabetic sensorimotor polyneuropathy. Muscle Nerve. 2012;45(1):126–7.
Rutkove SB, Kothari MJ, Raynor EM, Levy ML, Fadic R, Nardin RA. Sural/radial amplitude ratio in the diagnosis of mild axonal polyneuropathy. Muscle Nerve. 1997;20(10):1236–41.
Reeves ML, Seigler DE, Ayyar DR, Skyler JS. Medial plantar sensory response. Sensitive indicator of peripheral nerve dysfunction in patients with diabetes mellitus. Am J Med. 1984;76(5):842–6.
Killian JM, Foreman PJ. Clinical utility of dorsal sural nerve conduction studies. Muscle Nerve. 2001;24(6):817–20.
Kural MA, Karlsson P, Pugdahl K, Isak B, Fuglsang-Frederiksen A, Tankisi H. Diagnostic utility of distal nerve conduction studies and sural near-nerve needle recording in polyneuropathy. Clin Neurophysiol. 2017;128(9):1590–5.
Tavee JO, Polston D, Zhou L, Shields RW, Butler RS, Levin KH. Sural sensory nerve action potential, epidermal nerve fiber density, and quantitative sudomotor axon reflex in the healthy elderly. Muscle Nerve. 2014;49(4):564–9.
Lo YL, Xu LQ, Leoh TH, Dan YF, Tan YE, Nurjannah S, et al. Superficial peroneal sensory and sural nerve conduction studies in peripheral neuropathy. J Clin Neurosci. 2006;13(5):547–9.
AANEM policy statement on electrodiagnosis for distal symmetric polyneuropathy. Muscle Nerve. 2018;57(2):337–9.
Dyck PJ, Albers JW, Andersen H, Arezzo JC, Biessels GJ, Bril V, et al. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev. 2011;27(7):620–8.
Huang CR, Chang WN, Tsai NW, Lu CH. Serial nerve conduction studies in vitamin B12 deficiency-associated polyneuropathy. Neurol Sci. 2011;32(1):183–6.
Gordon PH, Wilbourn AJ. Early electrodiagnostic findings in Guillain-Barre syndrome. Arch Neurol. 2001;58(6):913–7.
Kuwabara S, Ogawara K, Mizobuchi K, Koga M, Mori M, Hattori T, et al. Isolated absence of F-waves and proximal axonal dysfunction in Guillain-Barre syndrome with antiganglioside antibodies. J Neurol Neurosurg Psychiatry. 2000;68(2):191–5.
Bromberg MB, Albers JW. Patterns of sensory nerve conduction abnormalities in demyelinating and axonal peripheral nerve disorders. Muscle Nerve. 1993;16(3):262–6.
Al-Shekhlee A, Hachwi RN, Preston DC, Katirji B. New criteria for early electrodiagnosis of acute inflammatory demyelinating polyneuropathy. Muscle Nerve. 2005;32(1):66–72.
Derksen A, Ritter C, Athar P, Kieseier BC, Mancias P, Hartung HP, et al. Sural sparing pattern discriminates Guillain-Barre syndrome from its mimics. Muscle Nerve. 2014;50(5):780–4.
Umapathi T, Li Z, Verma K, Yuki N. Sural-sparing is seen in axonal as well as demyelinating forms of Guillain-Barre syndrome. Clin Neurophysiol. 2015;126(12):2376–80.
Hiew FL, Rajabally YA. Sural sparing in Guillain-Barre syndrome subtypes: a reappraisal with historical and recent definitions. Clin Neurophysiol. 2016;127(2):1683–8.
Ye Y, Zhu D, Liu L, Wang K, Huang K, Hou C. Electrophysiological measurement at Erb’s point during the early stage of Guillain-Barre syndrome. J Clin Neurosci. 2014;21(5):786–9.
Albers JW, Donofrio PD, McGonagle TK. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 1985;8(6):528–39.
Hiraga A, Kuwabara S, Ogawara K, Misawa S, Kanesaka T, Koga M, et al. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barre syndrome. Neurology. 2005;64(5):856–60.
Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain-Barre syndrome: a critical revision and the need for an update. Clin Neurophysiol. 2012;123(8):1487–95.
Rajabally YA, Durand MC, Mitchell J, Orlikowski D, Nicolas G. Electrophysiological diagnosis of Guillain-Barre syndrome subtype: could a single study suffice? J Neurol Neurosurg Psychiatry. 2015;86(1):115–9.
Umapathi T, Tan EY, Kokubun N, Verma K, Yuki N. Non-demyelinating, reversible conduction failure in Fisher syndrome and related disorders. J Neurol Neurosurg Psychiatry. 2012;83(9):941–8.
Caliandro P, Stalberg E, Padua L. In response to “Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies”. Clin Neurophysiol. 2008;119(7):1694–5.
Tankisi H, Pugdahl K, Johnsen B, Fuglsang-Frederiksen A. Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies. Clin Neurophysiol. 2007;118(11):2383–92.
Olney RK, Lewis RA, Putnam TD, Campellone JV Jr. American Association of Electrodiagnostic M. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve. 2003;27(1):117–21.
Caliandro P, Stalberg E, La Torre G, Padua L. Sensitivity of conventional motor nerve conduction examination in detecting patchy demyelination: a simulated model. Clin Neurophysiol. 2007;118(7):1577–85.
Bromberg MB, Franssen H. Practical rules for electrodiagnosis in suspected multifocal motor neuropathy. J Clin Neuromuscul Dis. 2015;16(3):141–52.
Joint Task Force of the E, the PNS. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision. J Peripher Nerv Syst. 2010;15(4):295–301.
Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology. 1991;41(5):617–618.
Van den Bergh PY, Hadden RD, Bouche P, Cornblath DR, Hahn A, Illa I, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision. Eur J Neurol. 2010;17(3):356–63.
Thaisetthawatkul P, Logigian EL, Herrmann DN. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology. 2002;59(10):1526–32.
Katz JS, Wolfe GI, Bryan WW, Jackson CE, Amato AA, Barohn RJ. Electrophysiologic findings in multifocal motor neuropathy. Neurology. 1997;48(3):700–7.
Katz JS, Barohn RJ, Kojan S, Wolfe GI, Nations SP, Saperstein DS, et al. Axonal multifocal motor neuropathy without conduction block or other features of demyelination. Neurology. 2002;58(4):615–20.
Trojaborg W, Hays AP, van den Berg L, Younger DS, Latov N. Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies. Muscle Nerve. 1995;18(7):730–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Dhamne, M.C., Morren, J.A. (2021). Polyneuropathies. In: Galvez-Jimenez, N., Soriano, A., Morren, J.A. (eds) Electrodiagnostic Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-74997-2_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-74997-2_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-74996-5
Online ISBN: 978-3-030-74997-2
eBook Packages: MedicineMedicine (R0)